215 related articles for article (PubMed ID: 8319221)
21. Association of DNA content and proliferative activity with clinical outcome in patients with diffuse mixed cell and large cell non-Hodgkin's lymphoma.
Wooldridge TN; Grierson HL; Weisenburger DD; Armitage JO; Sanger WG; Collins MM; Pierson JL; Pauza ME; Fordyce R; Purtilo DT
Cancer Res; 1988 Nov; 48(22):6608-13. PubMed ID: 3052808
[TBL] [Abstract][Full Text] [Related]
22. Multivariate analysis of the prognostic significance of DNA-ploidy and S-phase fraction in ovarian cancer determined by flow cytometry following detection of cytokeratin-labeled tumor cells.
Kimmig R; Wimberger P; Hillemanns P; Kapsner T; Caspari C; Hepp H
Gynecol Oncol; 2002 Jan; 84(1):21-31. PubMed ID: 11748971
[TBL] [Abstract][Full Text] [Related]
23. Flow cytometric analysis of low grade B-cell non-Hodgkin's lymphoma: correlation between histology, immunophenotyping and cell cycle analysis.
Lackowska B; Wasilewska A; Gruchała A; Ryś J; Szklarski W; Niezabitowski A
Pol J Pathol; 1994; 45(4):263-9. PubMed ID: 7697327
[TBL] [Abstract][Full Text] [Related]
24. [Flowcytometry DNA analysis of oral and maxillofacial non-Hodgkin's lymphoma].
Ma L; He Z; Wu L; Cai Y; Huang H; Lei S
Hua Xi Kou Qiang Yi Xue Za Zhi; 2002 Jun; 20(3):193-6. PubMed ID: 12600064
[TBL] [Abstract][Full Text] [Related]
25. Predictive value of cell kinetics in endometrial adenocarcinoma.
Mariani L; Conti L; Antenucci A; Vercillo M; Atlante M; Gandolfo GM
Anticancer Res; 2000; 20(5B):3569-74. PubMed ID: 11131664
[TBL] [Abstract][Full Text] [Related]
26. Combined flow cytometry determination of S-phase fraction and DNA ploidy is an independent prognostic factor in node-negative invasive breast carcinoma: analysis of a series of 271 patients with stage I and II breast cancer.
Moureau-Zabotto L; Bouchet C; Cesari D; Uzan S; Lefranc JP; Antoine M; Genestie C; Deniaud-Alexandre E; Bernaudin JF; Touboul E; Fleury-Feith J
Breast Cancer Res Treat; 2005 May; 91(1):61-71. PubMed ID: 15868432
[TBL] [Abstract][Full Text] [Related]
27. Cell proliferation in ovarian carcinoma: superior accuracy of S-phase fraction (SPF) by DNA labeling index versus flow cytometric SPF, lack of independent prognostic power for SPF and DNA ploidy, and limited effect of SPF on tumor growth rate.
Meyer JS; Gersell DJ; Yim S
Gynecol Oncol; 2001 Jun; 81(3):466-76. PubMed ID: 11371140
[TBL] [Abstract][Full Text] [Related]
28. Determination of whole body circadian phase in lung cancer patients: melatonin vs. cortisol.
Mazzoccoli G; Giuliani F; Sothern RB
Cancer Epidemiol; 2012 Feb; 36(1):e46-53. PubMed ID: 22000330
[TBL] [Abstract][Full Text] [Related]
29. Flow analysis of DNA content and cell size in non-Hodgkin's lymphoma.
Diamond LW; Braylan RC
Cancer Res; 1980 Mar; 40(3):703-12. PubMed ID: 7471089
[TBL] [Abstract][Full Text] [Related]
30. Flow and image cytometric DNA analysis of postcardiac transplant lymphomas.
Kowal-Vern A; Swinnen LJ; Shankey V; Walloch J; Potocki D; Fisher SG; Molnar Z
Mod Pathol; 1994 Apr; 7(3):332-8. PubMed ID: 8058705
[TBL] [Abstract][Full Text] [Related]
31. Silver-stained nucleolar organizer regions in normal and dysplastic cervical lesions: correlation with DNA ploidy and S-phase fraction by flow cytometry.
Singh M; Prasad S; Kalra N; Singh U; Shukla Y
Oncology; 2006; 71(5-6):411-6. PubMed ID: 17785995
[TBL] [Abstract][Full Text] [Related]
32. Relations of proliferative activities of gastric carcinoma cells to lymphatic involvement, venous invasion and prognosis.
Wu YF; Xu HM; Chen JQ
Chin Med J (Engl); 2004 Oct; 117(10):1530-5. PubMed ID: 15498378
[TBL] [Abstract][Full Text] [Related]
33. Alteration of DNA ploidy status and cell proliferation induced by preoperative radiotherapy is a prognostic factor in rectal cancer.
Lammering G; Taher MM; Gruenagel HH; Borchard F; Porschen R
Clin Cancer Res; 2000 Aug; 6(8):3215-21. PubMed ID: 10955806
[TBL] [Abstract][Full Text] [Related]
34. S-phase fraction, 5-bromo-2'-deoxy-uridine labelling index, duration of S-phase, potential doubling time, and DNA index in benign and malignant brain tumors.
Struikmans H; Rutgers DH; Jansen GH; Tulleken CA; van der Tweel I; Battermann JJ
Radiat Oncol Investig; 1997; 5(4):170-9. PubMed ID: 9327496
[TBL] [Abstract][Full Text] [Related]
35. Circadian phase relationships between peripheral blood variables and bone marrow proliferative activity in clinical health.
Smaaland R; Sothern RB; Lote K; Sandberg S; Aakvaag A; Laerum OD
In Vivo; 1995; 9(4):379-89. PubMed ID: 8555438
[TBL] [Abstract][Full Text] [Related]
36. Measurement of DNA ploidy and proliferation rate in lung tumours by bromodeoxyuridine labelling index, S-phase fraction and AgNOR technique.
Gasińska A; Biesaga B; Kołodziejski L; Słonina D
Pol J Pathol; 1996; 47(4):201-7. PubMed ID: 9097713
[TBL] [Abstract][Full Text] [Related]
37. DNA ploidy and S-phase fraction by image and flow cytometry in breast cancer fine-needle cytopunctures.
Spyratos F; Briffod M
Mod Pathol; 1997 Jun; 10(6):556-63. PubMed ID: 9195572
[TBL] [Abstract][Full Text] [Related]
38. Prognostic evaluation of DNA flow cytometry and histo-morphological criteria in renal cell carcinoma.
Eskelinen M; Lipponen P; Nordling S
Anticancer Res; 1995; 15(5B):2279-83. PubMed ID: 8572637
[TBL] [Abstract][Full Text] [Related]
39. Prognostic relevance of non-Hodgkin's lymphomas cell cycle data.
Vucković J; Forenpoher G; Marusić M; UZarević B; Zemunik T
Neoplasma; 1998; 45(5):332-5. PubMed ID: 9921923
[TBL] [Abstract][Full Text] [Related]
40. DNA ploidy and S-phase fraction, but not p53 or NM23-H1 expression, predict outcome in colorectal cancer patients. Result of a 5-year prospective study.
Bazan V; Migliavacca M; Zanna I; Tubiolo C; Corsale S; Calò V; Amato A; Cammareri P; Latteri F; Grassi N; Fulfaro F; Porcasi R; Morello V; Nuara RB; Dardanoni G; Salerno S; Valerio MR; Dusonchet L; Gerbino A; Gebbia N; Tomasino RM; Russo A
J Cancer Res Clin Oncol; 2002 Dec; 128(12):650-8. PubMed ID: 12474051
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
